戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cell mass and function: the focal variant of congenital hyperinsulinism.
2 ium channel Kir6.2, respectively, results in congenital hyperinsulinism.
3 utant KATP channels previously identified in congenital hyperinsulinism.
4 surface lead to loss of channel function and congenital hyperinsulinism.
5        They represent a novel cause of focal congenital hyperinsulinism.
6 ssense Kir6.2 mutation, G156R, identified in congenital hyperinsulinism.
7 sible for the most common and severe form of congenital hyperinsulinism.
8 imination between focal and diffuse forms of congenital hyperinsulinism.
9 sults in loss of channel function as seen in congenital hyperinsulinism.
10  subunit of the channel, is a major cause of congenital hyperinsulinism.
11 A116P and V187D, identified in patients with congenital hyperinsulinism.
12 ly prevent cell surface expression and cause congenital hyperinsulinism.
13 nfants and children seen in the rare disease congenital hyperinsulinism.
14 cells, thereby causing insulin secretion and congenital hyperinsulinism.
15  regions to discover new molecular causes of congenital hyperinsulinism.
16 iabetes, whereas increased K(D) values cause congenital hyperinsulinism.
17 hanism for loss of KATP channel function and congenital hyperinsulinism and support the importance of
18     Thus, sulfonylureas may be used to treat congenital hyperinsulinism caused by certain K(ATP) chan
19                                              Congenital hyperinsulinism caused by loss of ATP-sensiti
20                                              Congenital hyperinsulinism causes persistent hypoglycemi
21                                A new form of congenital hyperinsulinism characterized by hypoglycemia
22  K(ATP) channel trafficking defects underlie congenital hyperinsulinism (CHI) cases unresponsive to t
23                                              Congenital hyperinsulinism (CHI) is a disease characteri
24                                              Congenital hyperinsulinism (CHI) is a disorder of unregu
25                                              Congenital hyperinsulinism (CHI) is a multifaceted disea
26                                              Congenital Hyperinsulinism (CHI) is a rare heterogeneous
27                                              Congenital hyperinsulinism (CHI) is most commonly caused
28  choice for insulinomas and focal lesions in congenital hyperinsulinism (CHI) is surgery.
29                                              Congenital hyperinsulinism (CHI) may be due to diffuse o
30 rgery with curative intent can be offered to congenital hyperinsulinism (CHI) patients, provided that
31 ory subunit, sulfonylurea receptor 1, causes congenital hyperinsulinism (CHI), a neonatal disease cha
32 cal excitability and secretion, resulting in congenital hyperinsulinism (CHI), whereas gain-of-functi
33 and in humans lead to the clinical condition congenital hyperinsulinism (CHI).
34 ity and insulin hypersecretion, resulting in congenital hyperinsulinism (CHI).
35 f glutamate dehydrogenase (GDH) in a form of congenital hyperinsulinism (GDH-HI) is providing a model
36 cation to treat nesidioblastosis and diffuse congenital hyperinsulinism has varying efficacy and caus
37                                              Congenital hyperinsulinism (HI) is a genetic disorder in
38 on and severe form of diazoxide-unresponsive congenital hyperinsulinism (HI) require a pancreatectomy
39                                              Congenital hyperinsulinism (HI), a beta cell disorder mo
40 icacy of this form of linkage-mapping, using congenital hyperinsulinism (HI), an autosomal recessive
41 ubunits underlie human neonatal diabetes and congenital hyperinsulinism (HI), respectively.
42  are responsible for the most common form of congenital hyperinsulinism in children.
43                                              Congenital hyperinsulinism in infancy (CHI) is character
44                                      Diffuse congenital hyperinsulinism in infancy (CHI-D) arises fro
45                                              Congenital hyperinsulinism is a condition of dysregulate
46                                              Congenital hyperinsulinism is a disorder of pancreatic b
47                                              Congenital hyperinsulinism is characterized by persisten
48 reatment of insulinomas and focal lesions in congenital hyperinsulinism is invasive and carries major
49  KATP channels cause the most severe form of congenital hyperinsulinism (KATPHI).
50                                              Congenital hyperinsulinism of infancy (CHI) can be cause
51                                              Congenital hyperinsulinism of infancy (CHI) can be cause
52 evere recessively inherited diffuse forms of congenital hyperinsulinism or, when associated with loss
53                                 Infants with congenital hyperinsulinism owing to inactivating mutatio
54 annel expression and function in a subset of congenital hyperinsulinism patients.
55 he loss of channel function phenotype in the congenital hyperinsulinism patients.
56 hannels with reduced activity are a cause of congenital hyperinsulinism, whereas hyperactive channels
57 annel function are typically associated with congenital hyperinsulinism, whereas those that increase